Seguir
Matteo Allegretti
Matteo Allegretti
IRCCS Regina Elena National Cancer Institute
Dirección de correo verificada de ifo.gov.it
Título
Citado por
Citado por
Año
Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias
MR Ricciardi, S Mirabilii, M Allegretti, R Licchetta, A Calarco, MR Torrisi, ...
Blood, The Journal of the American Society of Hematology 126 (16), 1925-1929, 2015
2012015
Liquid biopsy and PCR-free ultrasensitive detection systems in oncology
A Finotti, M Allegretti, J Gasparello, P Giacomini, DA Spandidos, G Spoto, ...
International Journal of Oncology 53 (4), 1395-1434, 2018
782018
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
M Allegretti, A Fabi, S Buglioni, A Martayan, L Conti, E Pescarmona, ...
Journal of Experimental & Clinical Cancer Research 37, 1-3, 2018
652018
The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia
M Allegretti, MR Ricciardi, R Licchetta, S Mirabilii, S Orecchioni, ...
Scientific reports 5 (1), 18137, 2015
442015
Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia
S Iacovelli, MR Ricciardi, M Allegretti, S Mirabilii, R Licchetta, P Bergamo, ...
Oncotarget 6 (31), 32089, 2015
372015
Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA)
J Gasparello, M Allegretti, E Tremante, E Fabbri, CA Amoreo, P Romania, ...
Journal of Experimental & Clinical Cancer Research 37, 1-11, 2018
332018
Precision diagnostics of Ewing’s sarcoma by liquid biopsy: circulating EWS-FLI1 fusion transcripts
M Allegretti, B Casini, C Mandoj, S Benini, L Alberti, M Novello, E Melucci, ...
Therapeutic Advances in Medical Oncology 10, 1758835918774337, 2018
332018
A distinctive microRNA (miRNA) signature in the blood of colorectal cancer (CRC) patients at surgery
J Gasparello, C Papi, M Allegretti, E Giordani, F Carboni, S Zazza, ...
Cancers 12 (9), 2410, 2020
312020
Direct plasmonic detection of circulating RAS mutated DNA in colorectal cancer patients
R D'Agata, N Bellassai, M Allegretti, A Rozzi, S Korom, A Manicardi, ...
Biosensors and Bioelectronics 170, 112648, 2020
282020
Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
M Allegretti, G Cottone, F Carboni, E Cotroneo, B Casini, E Giordani, ...
Journal of Experimental & Clinical Cancer Research 39, 1-12, 2020
242020
Detection of tumor DNA in human plasma with a functional PLL-based surface layer and plasmonic biosensing
N Bellassai, R D’Agata, A Marti, A Rozzi, S Volpi, M Allegretti, R Corradini, ...
ACS sensors 6 (6), 2307-2319, 2021
212021
Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer
M Allegretti, A Fabi, E Giordani, C Ercolani, P Romania, C Nisticò, ...
Molecular Cancer 20, 1-6, 2021
102021
Bioassay engineering: a combined label-free and fluorescence approach to optimize HER2 detection in complex biological media
A Sinibaldi, A Doricchi, T Pileri, M Allegretti, N Danz, P Munzert, ...
Analytical and Bioanalytical Chemistry 412, 3509-3517, 2020
92020
Foa
MR Ricciardi, S Mirabilii, M Allegretti, R Licchetta, A Calarco, MR Torrisi
R., Nicolai, R., Peluso, G., and Tafuri, A, 1925-1929, 2015
62015
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
B Cerbelli, A Pisano, MG Pignataro, A Pernazza, A Botticelli, M Carosi, ...
Clinical and Experimental Medicine 23 (5), 1641-1647, 2023
42023
Two distinct TP53 mutations in HNSCC primary tumor: Only one circulates in the blood.
F Ganci, M Allegretti, V Manciocco, F Fiorentino, G Sanguineti, ...
Oral Oncology 115, 105096-105096, 2020
32020
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world
P Giacomini, F Valenti, M Allegretti, M Pallocca, F De Nicola, L Ciuffreda, ...
Journal of Translational Medicine 21 (1), 725, 2023
22023
TOOLBOX: Strep‑Tagged nano‑assemblies of antibody‑drug‑conjugates (ADC) for modular and conditional cancer drugging Corrigendum in/10.3892/or. 2021.8110
E Tremante, L Sibilio, F Centola, N Knutti, G Holzapfel, I Manni, ...
Oncology reports 45 (5), 1-9, 2021
22021
Combined label-free/fluorescence platform based on Bloch surface waves biochips for cancer biomarker detection
N Danz, A Sinibaldi, M Allegretti, E Sepe, P Munzert, P Giacomini, ...
Biophotonics: Photonic Solutions for Better Health Care VI 10685, 124-132, 2018
22018
Erratum: The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia
M Allegretti, MR Ricciardi, R Licchetta, S Mirabilii, S Orecchioni, ...
Scientific Reports 6 (1), 20743, 2016
22016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20